In this Monographic issue on Oligonucleotides & Peptides we have foreseen a Panel discussion on Peptides involving companies linked to their synthesis. In the next few pages the reader will have an update on the status of progress reached by peptide synthesis and technologies, the high quality achieved, the regulatory and therapeutical application hurdles such as bioavailability and what the future holds and where peptides are aiming at (for example Personalised medicines). 

The following Players have joined this initiative:

Daniel Bourgin
Business Development
Dr. Reddy’s Custom Pharma Services (CPS)

What has b ... ... ...